GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cerus Corp (FRA:CU2) » Definitions » 3-Year Revenue Growth Rate

Cerus (FRA:CU2) 3-Year Revenue Growth Rate : 15.60% (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Cerus 3-Year Revenue Growth Rate?

Cerus's Revenue per Share for the three months ended in Dec. 2023 was €0.24.

During the past 12 months, Cerus's average Revenue per Share Growth Rate was -5.60% per year. During the past 3 years, the average Revenue per Share Growth Rate was 15.60% per year. During the past 5 years, the average Revenue per Share Growth Rate was 15.60% per year. During the past 10 years, the average Revenue per Share Growth Rate was 7.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.

During the past 13 years, the highest 3-Year average Revenue per Share Growth Rate of Cerus was 52.40% per year. The lowest was -44.50% per year. And the median was 9.15% per year.


Competitive Comparison of Cerus's 3-Year Revenue Growth Rate

For the Medical Devices subindustry, Cerus's 3-Year Revenue Growth Rate, along with its competitors' market caps and 3-Year Revenue Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cerus's 3-Year Revenue Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cerus's 3-Year Revenue Growth Rate distribution charts can be found below:

* The bar in red indicates where Cerus's 3-Year Revenue Growth Rate falls into.



Cerus 3-Year Revenue Growth Rate Calculation

This is the 3-year average growth rate of Revenue per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average Revenue per Share growth rate.


Cerus  (FRA:CU2) 3-Year Revenue Growth Rate Explanation

Revenue per Share is the amount of Revenue per outstanding share of the company's stock.

Revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top. Revenue per share growth rate is used in calculating Predictability Rank, companies with more consistent revenue and earnings growth are ranked high with predictability.


Cerus 3-Year Revenue Growth Rate Related Terms

Thank you for viewing the detailed overview of Cerus's 3-Year Revenue Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Cerus (FRA:CU2) Business Description

Traded in Other Exchanges
Address
1220 Concord Avenue, Suite 600, Concord, CA, USA, 94520
Cerus Corp is a biomedical products company focused on the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria, and parasites. The company sells its INTERCEPT platelet and plasma systems in the United States of America, Europe, the Commonwealth of Independent States countries, the Middle East, and selected countries in other regions around the world. The firm continues to operate in only one segment: Blood safety and generates revenue from the same.

Cerus (FRA:CU2) Headlines

No Headlines